These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32790740)

  • 1. Risks of requiring a dedicated molecular specimen for HIV diagnosis and a potential strategy for mitigation.
    Bailey AL; Anderson N
    PLoS One; 2020; 15(8):e0237580. PubMed ID: 32790740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in west Africa.
    Brattegaard K; Kouadio J; Adom ML; Doorly R; George JR; De Cock KM
    AIDS; 1993 Jun; 7(6):883-5. PubMed ID: 8395857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world performance of the new US HIV testing algorithm in medical settings.
    Marson KG; Marlin R; Pham P; Cohen SE; Jones D; Roemer M; Peters PJ; Haller B; Pilcher CD
    J Clin Virol; 2017 Jun; 91():73-78. PubMed ID: 28434809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy.
    Adhikari EH; Macias D; Gaffney D; White S; Rogers VL; McIntire DD; Roberts SW
    Am J Obstet Gynecol; 2018 Oct; 219(4):408.e1-408.e9. PubMed ID: 29913173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Application Evaluation of a Fourth-Generation HIV Antigen Antibody Combination Screening Assay.
    Han H; Huang Y; Dong Q; Huang Y; Lu J; Wang W; Chen K
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting.
    Chacón L; Mateos ML; Holguín Á
    J Clin Virol; 2017 Jul; 92():11-13. PubMed ID: 28501753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of turnaround time and total cost of HIV testing before and after implementation of the 2014 CDC/APHL Laboratory Testing Algorithm for diagnosis of HIV infection.
    Chen DJ; Yao JD
    J Clin Virol; 2017 Jun; 91():69-72. PubMed ID: 28461133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
    Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
    Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm.
    Parker J; Carrasco AF; Chen J
    J Clin Virol; 2019 Jul; 116():1-3. PubMed ID: 30981082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misdiagnosis of HIV infection during a South African community-based survey: implications for rapid HIV testing.
    Kufa T; Kharsany AB; Cawood C; Khanyile D; Lewis L; Grobler A; Chipeta Z; Bere A; Glenshaw M; Puren A
    J Int AIDS Soc; 2017 Aug; 20(Suppl 6):21753. PubMed ID: 28872274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Utility of HIV-1/2 Ab Immunochromatographic Assay as an Additive Test for HIV Screen-Positive Patients.
    Yoo SJ
    Ann Clin Lab Sci; 2020 Mar; 50(2):274-277. PubMed ID: 32366569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample-to-cutoff ratios using Architect HIV Ag/Ab Combo: The influence with the results of supplemental tests and optimal cutoff value to predict HIV infection.
    Wang L; Wang JY; Tian XD; Ruan JX; Yu Y; Yan F
    J Clin Lab Anal; 2019 Jun; 33(5):e22866. PubMed ID: 30803030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance evaluation and optimized reporting workflow for HIV diagnostic screening and confirmatory tests in a low prevalence setting.
    Wiredja D; Ritchie TA; Tam G; Hogan CA; Pinsky B; Shi RZ
    J Clin Virol; 2021 Dec; 145():105020. PubMed ID: 34736075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial.
    Crucitti T; Taylor D; Beelaert G; Fransen K; Van Damme L
    Clin Vaccine Immunol; 2011 Sep; 18(9):1480-5. PubMed ID: 21752945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance evaluation of the Bio-Rad Geenius HIV 1/2 supplemental assay.
    Luo W; Sullivan V; Smith T; Peters PJ; Gay C; Westheimer E; Cohen SE; Owen SM; Masciotra S
    J Clin Virol; 2019 Feb; 111():24-28. PubMed ID: 30594702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test.
    Brust S; Duttmann H; Feldner J; Gürtler L; Thorstensson R; Simon F
    J Virol Methods; 2000 Nov; 90(2):153-65. PubMed ID: 11064116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunofluorescence assay in India for confirmation of HIV-1 infection using a T-cell line infected with defective HIV-1.
    Bala M; Arias JF; Deb M; Ikuta K
    Int J Infect Dis; 2010 Dec; 14(12):e1093-8. PubMed ID: 20952236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of three automated fourth-generation combined HIV antigen/antibody assays in large-scale screening of blood donors and clinical samples.
    Malm K; von Sydow M; Andersson S
    Transfus Med; 2009 Apr; 19(2):78-88. PubMed ID: 19320855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection.
    Li L; Puddicombe D; Champagne S; Jassem A; Krajden M; Merrick L; Lowe C; Payne M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1589-1593. PubMed ID: 29862422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population.
    Fordan S; Bennett B; Lee M; Crowe S
    J Clin Virol; 2017 Jun; 91():79-83. PubMed ID: 28434810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.